Anodyne Corporation

Anodyne Nanotech is a biotechnology company focused on developing a proprietary transdermal delivery platform for large molecules, such as monoclonal antibodies and peptides. The company's core technology, the Hero Patch, utilizes porous microneedles to enable the painless, self-administered delivery of biologics that typically require clinical injections or infusions. Anodyne's internal pipeline includes programs for osteoporosis (AN-001) and rheumatoid arthritis (AN-002), and the company has established collaborations with major pharmaceutical firms to adapt its platform for various biologic therapies. By combining advanced material science with drug delivery, Anodyne aims to improve patient adherence and therapeutic efficacy across a range of chronic conditions.